Publication | Closed Access

Multiplex immunoassay measurement of amyloid-β42 to amyloid-β40 ratio in plasma discriminates between dementia due to Alzheimer’s disease and dementia not due to Alzheimer’s disease

Neurodegenerative DiseasesAlzheimer's DiseaseAgingMedicineDementiaImmunologyBiomarkersNeurochemical BiomarkersNeurologyAging-associated DiseaseNeurodegenerationPlasma DiscriminatesAlzheimer ’Amyloid-β40 RatioProtective MechanismsHealth Sciences